ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "risk assessment and spondylarthritis"

  • Abstract Number: 2759 • ACR/ARHP Annual Meeting 2016

    Prevalence of Comorbidities and Risk Factors of Spondyloarthritis in Latin America: A Comparative Study with the General Population: Data from the Multinational ASAS-Comospa Study

    WILSON BAUTISTA-MOLANO1,2, Robert Landewé3, Anna Molto4, Rubén Burgos-Vargas5, José Antonio Maldonado-Cocco6, Rafael Valle-Oñate7 and Désirée van der Heijde8, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology Department, School of Medicine, UMNG / HMC, Bogotá, Colombia, 3Amsterdam Medical Center, Amsterdam, Netherlands, 4Hopital Cochin, Paris Descartes University, Paris, France, 5Rheumatology, Hospital General de Mexico, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico, 6Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 7Rheumatology Department, School of Medicine, UMNG / HMC, Bogota, Colombia, 8Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose:  Increased risk of several comorbidities has been reported in spondyloarthritis (SpA). Data and knowledge regarding the prevalence of these comorbidities and risk factors in…
  • Abstract Number: 853 • ACR/ARHP Annual Meeting 2014

    Cancer Incidence in TNF Inhibitor Treated Patients with Axial Spondyloarthritis and Psoriatic Arthritis – a Study  from the ARTIS and Danbio Registers        

    Johan Askling1, Lene Dreyer2, Merete Lund Hetland3, Lennart Jacobsson4, Lars-Erik Kristensen5, Bente Glintborg6, . ARTIS and DANBIO study groups7 and Karin Hellgren8, 1Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden, 2Gentofte University Hospital, Hellreup, Denmark, 3Glostrup University Hospital, Glostrup, Denmark, 4Sahlgrenska Academy, Gothenburg, Sweden, 5Lund University, Lund, Sweden, 6Gentofte University Hospital, Gentofte, Denmark, 7Karolinska Institutet, stockholm, Sweden, 8Karolinska Institutet, Stockholm, Sweden

    Background/Purpose Most studies of the safety profile of TNF inhibitors (TNFi) - in particular in relation to cancer risks - have been performed in patients…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology